SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-021435
Filing Date
2023-06-15
Accepted
2023-06-15 16:18:02
Documents
12
Period of Report
2023-06-09
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36360
  Complete submission text file 0001493152-23-021435.txt   211177

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eton-20230609.xsd EX-101.SCH 2965
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eton-20230609_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eton-20230609_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3731
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38738 | Film No.: 231017584
SIC: 2834 Pharmaceutical Preparations